These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2522915)
1. Skin fibroblasts from patients with the genetic disorder hereditary hemorrhagic telangiectasia compared with ataxia-telangiectasia fibroblasts in their response to the radiomimetic drug neocarzinostatin. Becker Y; Tabor E Isr J Med Sci; 1989 Feb; 25(2):81-6. PubMed ID: 2522915 [TBL] [Abstract][Full Text] [Related]
2. Transfection of SV40-transformed ataxia-telangiectasia fibroblasts with mouse DNA corrects hypersensitivity to neocarzinostatin and activates fibronectin gene expression. Becker Y; Asher Y; Tabor E Isr J Med Sci; 1992 Dec; 28(12):837-47. PubMed ID: 1337542 [TBL] [Abstract][Full Text] [Related]
3. Cellular hypersensitivity to neocarzinostatin in ataxia-telangiectasia skin fibroblasts. Shiloh Y; Tabor E; Becker Y Cancer Res; 1982 Jun; 42(6):2247-9. PubMed ID: 6210429 [TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity of cultured ataxia-telangiectasia cells to etoposide. Henner WD; Blazka ME J Natl Cancer Inst; 1986 Jun; 76(6):1007-11. PubMed ID: 2423735 [TBL] [Abstract][Full Text] [Related]
5. Reduced inhibition of replicon initiation and chain elongation by neocarzinostatin in skin fibroblasts from patients with ataxia telangiectasia. Shiloh Y; Becker Y Biochim Biophys Acta; 1982 Dec; 721(4):485-8. PubMed ID: 6218825 [TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity and reduced inhibition of DNA synthesis in ataxia telangiectasia lymphoblasts treated with low levels of neocarzinostatin. Babilon RW; Soprano KJ; Henderson EE Mutat Res; 1985 Jul; 146(1):79-87. PubMed ID: 3158810 [TBL] [Abstract][Full Text] [Related]
7. Induction and repair of DNA damage in normal and ataxia-telangiectasia skin fibroblasts treated with neocarzinostatin. Shiloh Y; van der Schans GP; Lohman PH; Becker Y Carcinogenesis; 1983; 4(7):917-21. PubMed ID: 6223717 [TBL] [Abstract][Full Text] [Related]
8. Effects of the DNA strand-cleaving antitumor agent, streptonigrin, on ataxia telangiectasia cells. Taylor AM; Flude E; Garner CM; Campbell JB; Edwards MJ Cancer Res; 1983 Jun; 43(6):2700-3. PubMed ID: 6850587 [TBL] [Abstract][Full Text] [Related]
9. Repair of potentially lethal and sublethal damage induced by neocarzinostatin in normal and ataxia-telangiectasia skin fibroblasts. Shiloh Y; Tabor E; Becker Y Biochem Biophys Res Commun; 1983 Jan; 110(2):483-90. PubMed ID: 6220700 [TBL] [Abstract][Full Text] [Related]
10. Ubiquitination capabilities in response to neocarzinostatin and H(2)O(2) stress in cell lines from patients with ataxia-telangiectasia. Taylor A; Shang F; Nowell T; Galanty Y; Shiloh Y Oncogene; 2002 Jun; 21(28):4363-73. PubMed ID: 12080467 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of mammalian deoxyribonucleic acid synthesis by neocarzinostatin: selective effect on replicon initiation in CHO cells and resistant synthesis in ataxia telangiectasia fibroblasts. Povirk LF; Goldberg IH Biochemistry; 1982 Nov; 21(23):5857-62. PubMed ID: 6217834 [TBL] [Abstract][Full Text] [Related]
12. Induction and repair of DNA and chromosome damage by neocarzinostatin in quiescent normal human fibroblasts. Hittelman WN; Pollard M Cancer Res; 1982 Nov; 42(11):4584-90. PubMed ID: 6215119 [TBL] [Abstract][Full Text] [Related]
13. Human cDNA clones that modify radiomimetic sensitivity of ataxia-telangiectasia (group A) cells. Ziv Y; Bar-Shira A; Jorgensen TJ; Russell PS; Sartiel A; Shows TB; Eddy RL; Buchwald M; Legerski R; Schimke RT; Shiloh Y Somat Cell Mol Genet; 1995 Mar; 21(2):99-111. PubMed ID: 7570189 [TBL] [Abstract][Full Text] [Related]
14. Radioresistant DNA synthesis in SV40-immortalized ataxia telangiectasia fibroblasts. Jorgensen TJ; Russell PS; McRae DA Radiat Res; 1995 Aug; 143(2):219-23. PubMed ID: 7631015 [TBL] [Abstract][Full Text] [Related]
15. Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity. Duchaud E; Ridet A; Stoppa-Lyonnet D; Janin N; Moustacchi E; Rosselli F Cancer Res; 1996 Mar; 56(6):1400-4. PubMed ID: 8640831 [TBL] [Abstract][Full Text] [Related]
16. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth. Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904 [TBL] [Abstract][Full Text] [Related]
17. Increased level of bleomycin-induced chromosome breakage in ataxia telangiectasia skin fibroblasts. Shaham M; Becker Y; Lerer I; Voss R Cancer Res; 1983 Sep; 43(9):4244-7. PubMed ID: 6191860 [TBL] [Abstract][Full Text] [Related]
18. Evidence of DNA repair/processing defects in cultured skin fibroblasts from breast cancer patients. Hannan MA; Siddiqui Y; Rostom A; Al-Ahdal MN; Chaudhary MA; Kunhi M Cancer Res; 2001 May; 61(9):3627-31. PubMed ID: 11325831 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of novel DNA sugar damage by an antitumour protein antibiotic. Goldberg IH; Kappen LS; Povirk LF; Chin DH Drugs Exp Clin Res; 1986; 12(6-7):495-505. PubMed ID: 2943568 [TBL] [Abstract][Full Text] [Related]
20. The potentiation by caffeine of X-ray damage to cultured human skin fibroblasts from normal subjects and ataxia-telangiectasia patients. Furcinitti PS Radiat Res; 1983 Jul; 95(1):197-204. PubMed ID: 6878630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]